Quan Lin is a seasoned professional in the field of clinical research and medical development, currently serving as Sr. Medical Director at Adaptimmune since December 2019, focusing on drug development for various cancers. Prior experience includes roles as Director of Clinical Research at KeChow Pharma, Sr. Manager of Clinical Research at Klus Pharma, and Clinical Studies Supervisor at the University of Texas M.D. Anderson Cancer Center. Quan possesses extensive expertise in strategic planning, clinical trial design, and regulatory compliance, with a strong background in hematology and cancer research. Educational credentials include an MD and MS from Shanghai Second Medical University, along with a Clinical Research Monitoring and Coordination certificate from Michigan State University.
This person is not in any teams
This person is not in any offices